The Present research was conducted to evaluate the ability of Deferasirox and Deferiprone (L1) chelators as single and combined therapies in removing lead from biological system. Lead at two doses of 20 (low dose drinking ...

The Cu(II) complexes [Cu(Tppz)(Dipic)] ⋅ 8H2O (I) and [Pb2(Tppz)Cl4]n (II), where Tppz,

H2Dipic are 2,3,5,6-tetrakis(2-pyridyl)pyrazine, dipicolinic acid, respectively, have been synthesized and

characterized ...

Abstract

The hypothesis that two known chelators deferasirox (4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid) and desferrioxamine (DFO) might be more efficient as combined treatment than as monotherapies ...